Loading clinical trials...

Not Yet RecruitingNANCT06402214

The 'Lombard Effect' in Patients Affected by Adductor Laryngeal Dystonia

Adductory spasmodic dysphonia (AdSD) is a rare condition characterised by irregular and uncontrolled voice interruptions, most commonly affecting women around the age of 45. The diagnosis is clinical ...

Lead sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Maria Raffaella Marchese, MD, PhD

CONTACT

+39-3391144556 raffaellamarchese@gmail.com

Lucia DAlatri, MD, PhD

CONTACT

+39-630154244 lucia.dalatri@policlinicogemelli.it

Related studies

COMPLETEDPhase 1/2

DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia

NCT05158166 · Adductor Spasmodic Dysphonia, Voice Disorders, and more

COMPLETEDNA

Assessment of Laryngopharyngeal Sensation in Adductor Spasmodic Dysphonia

NCT05158179 · Spasmodic Dysphonia, Adductor Spasmodic Dysphonia, and more

COMPLETEDNA

Effects of Vocal Exercises for Spasmodic Dysphonia

NCT03349086 · Adductor Spasmodic Dysphonia

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 7, 2024Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhaseNA

Enrollment18

Start dateMay 2024

Last updatedMay 7, 2024

Condition

Adductor Spasmodic Dysphonia

Locations shown

Fondazione Policlinico Universitario A. Gemelli IRCCS

Roma

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 7, 2024Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions